Carolyn Beaver - Feb 12, 2025 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Role
Director
Signature
/s/ Yuichi Iwaki, attorney-in-fact
Stock symbol
MNOV
Transactions as of
Feb 12, 2025
Transactions value $
$0
Form type
4
Date filed
2/14/2025, 04:49 PM
Previous filing
Sep 19, 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MNOV Stock Option (Right to Buy) Award $0 +24.5K $0.00 24.5K Feb 12, 2025 Common Stock 24.5K $1.84 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in four equal installments on May 12, 2025, August 12, 2025, November 12, 2025 and February 12, 2026, subject to continued service with the Company.